Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 53-62 , January 2009

Integrating Biologically Targeted Therapy in Head and Neck Squamous Cell Carcinomas

  • Quynh-Thu Le

      Affiliations

    • Department of Radiation Oncology, Stanford University, Stanford, CA
    • Corresponding Author InformationAddress reprint requests to Quynh-Thu Le, MD, Department of Radiation Oncology, Stanford University, 875 Blake Wilbur Dr, MC 5847, Stanford, CA 94305-5847
    • ,
  • David Raben

      Affiliations

    • Department of Radiation Oncology, University of Colorado Denver, Aurora, CO

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the National Institute of Health grants 1 R01 CA118582-01 and PO1- CA67166 (QTL). Investigator initiated study from GSK (QTL).

PII: S1053-4296(08)00064-7

doi: 10.1016/j.semradonc.2008.09.010

Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 53-62 , January 2009

Article Tools

* Image Usage & Resolution